Monday, Jul 15, 2024
Update At 14:00    USD/EUR 0,92  ↑+0.0002        USD/JPY 151,69  ↑+0.174        USD/KRW 1.347,35  ↑+6.1        EUR/JPY 164,16  ↑+0.143        Crude Oil 85,49  ↓-0.76        Asia Dow 3.838,83  ↑+1.8        TSE 1.833,50  ↑+4.5        Japan: Nikkei 225 40.846,59  ↑+448.56        S. Korea: KOSPI 2.756,23  ↓-0.86        China: Shanghai Composite 3.015,74  ↓-15.745        Hong Kong: Hang Seng 16.512,92  ↓-105.4        Singapore: Straits Times 3,27  ↑+0.018        DJIA 22,58  ↓-0.23        Nasdaq Composite 16.315,70  ↓-68.769        S&P 500 5.203,58  ↓-14.61        Russell 2000 2.070,16  ↓-4.0003        Stoxx Euro 50 5.064,18  ↑+19.99        Stoxx Europe 600 511,09  ↑+1.23        Germany: DAX 18.384,35  ↑+123.04        UK: FTSE 100 7.930,96  ↑+13.39        Spain: IBEX 35 10.991,50  ↑+39.3        France: CAC 40 8.184,75  ↑+33.15        

Next-generation medical equipment for a healthier society

Article - August 25, 2023

With beginnings as a trader and then moving into manufacturing, Japan Lifeline is a company that operates as a ‘Two-way Player’ in the medical equipment field. 

Japan Lifeline (JLL) is a prominent player in the medical equipment industry, specializing in the arrhythmias, cardiovascular and gastrointestinal fields. Providing comprehensive solutions to medical institutions and patients, the company is at the forefront of innovation in its field.

JLL has a nationwide sales force covering 48 sales offices and serving major medical facilities across Japan. Its sales representatives are in close contact with end-users, such as doctors and medical institutions, to better understand their needs and provide them with customized solutions. Furthermore, JLL has a strong track record of quality and safety management with an in-house regulatory affairs system to ensure the safety and effectiveness of its products and services.

“We have a unique role to fulfill, one that J&J, Boston or Medtronic cannot play,” says president and CEO Keisuke Suzuki.

The ‘BeeAT’ internal atrial defibrillation catheter is one of the company’s major products, which reduces the risk of severe burns and enables less invasive treatment. Its patented multi-lumen shaft design stores positive and negative poles separately, minimizing the risk of insulation breakdown and short-circuiting during cardiac ablation procedures. This design improves patient safety and operator efficiency.

Another flagship product, ‘FROZENIX’ is designed for the Frozen Elephant Trunk technique to treat aortic aneurysms and dissection, with a simple implant procedure and unique stent design for optimal long-term performance. The individually hand-knitted stent ensures conformity to the aortic arch without undue stress.